NextGenMicrofluidics

MICROFLUIDIC LAB-ON-A-FOIL SYSTEMS There is great potential for polymer foil-based microfluidic lab-on-a-chip systems - so-called lab-on-a-foil systems - particularly in medicine, pharmaceuticals, production and analysis. The H2020 project NextGenMicrofluidics combines the competencies of 21 companies and research organizations along the entire value chain in the development of microfluidic lab-on-a-foil systems and offers services for the development and production of these systems for companies - from start-ups to large-scale industry. NextGenMicrofluidics is addressing this challenge by establishing an Open Innovation Test Bed, which will combine technologies such as high-resolution printing of biomolecules in the form of the world's first roll-to-roll microarray spotter as well as a unique continuous roll-to-roll production line for high-throughput manufacturing for foil-based microfluidics. Injection molding and wafer-based glass and silicon processing will complement the platform. All of these together enable mass production of several million lab-on-a-foil systems per year, important, for example, for the production of rapid tests for medical diagnosis with possible application in COVID-19 detection. Parallel to technical development NextGenMicrofluidics offers business advice to attract new venture capital. NextGenMicrofluidics creates value for its customers through: • Unique technology offer to develop and manufacture microfluidic systems • Open access for testing of new technologies via the open innovation test bed • One single entry point to this research and development services • Production as a service • Quality assured • Access to venture capital This project has received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 862092 with a total volume of almost 15 million Euros for the next 4 years. Posts and shares reflect only the views of the project owner.